What are the most common side effects? | Lyrica

Language English

Question:

What are the most common side effects?

Answer:

The 2 most common side effects of LYRICA are dizziness and sleepiness. Across all clinical studies, dizziness occurred in 30% of LYRICA patients, compared with 8% of patients taking a placebo. Sleepiness occurred in 23% of LYRICA patients, compared with 8% of patients taking a placebo. For some people, dizziness and sleepiness went away over time. For others, these lasted throughout the course of the studies.

Two Most Common Side Effects with LYRICA in Clinical Studies

Indication	How long dizziness lasted on average	How long sleepiness lasted on average
Fibromyalgia	About 2.5 Weeks	About 5 Weeks
Diabetic Nerve Pain	1 to 2 Weeks	4 to 6 Weeks
Spinal Cord Injury Nerve Pain	About 1.5 Weeks	Over 10 Weeks
Pain After Shingles	1 to 7 Weeks	3 to 8 Weeks
Partial Onset Seizures in Adults with Epilepsy	2 to 4 Weeks	4 to 8 Weeks

Other side effects in these studies include dry mouth, swelling of the hands and feet, blurred vision, weight gain, trouble concentrating. These side effects were generally mild to moderate.

LYRICA may also cause serious, even life threatening, allergic reactions. Stop taking LYRICA and call your doctor right away if you have any signs of a serious allergic reaction. Some signs are swelling of your face, mouth, lips, gums, tongue, throat or neck or if you have any trouble breathing, or have a rash, hives or blisters.

If you stop taking LYRICA suddenly, you may have headaches, nausea, diarrhea, or trouble sleeping. If you have epilepsy and you stop taking LYRICA suddenly, you may have seizures more often. If you and your doctor do decide you need to stop taking LYRICA, he or she will help you stop gradually.

Please see additional Important Safety Information below.

Treat:

LYRICA

PDF version

Expand For Important Safety Information & Indications

Important Safety Information & Indications

Important Safety Information

LYRICA is not for everyone.

LYRICA may cause serious, even life-threatening, allergic reactions. Stop taking LYRICA and call your doctor right away if you have any signs of a serious allergic reaction. Some signs are swelling of your face, mouth, lips, gums, tongue, throat or neck or if you have any trouble breathing, or have a rash, hives, or blisters.

Drugs used to treat seizures increase the risk of suicidal thoughts or behavior. LYRICA may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Patients, family members, or caregivers should call the doctor right away if they notice suicidal thoughts or actions, thoughts of self-harm, or any unusual changes in mood or behavior. These changes may include new or worsening depression, anxiety, restlessness, trouble sleeping, panic attacks, anger, irritability, agitation, aggression, dangerous impulses or violence, or extreme increases in activity or talking. If you have suicidal thoughts or actions, do not stop LYRICA without first talking to your doctor.

LYRICA may cause swelling of your hands, legs, and feet, which can be serious for people with heart problems. LYRICA may cause dizziness and sleepiness. You should not drive or work with machines until you know how LYRICA affects you. Also, tell your doctor right away about muscle pain or problems along with feeling sick and feverish, or any changes in your eyesight including blurry vision or if you have any kidney problems or get dialysis.

Some of the most common side effects of LYRICA are dizziness, blurry vision, weight gain, sleepiness, trouble concentrating, swelling of your hands and feet, dry mouth, and feeling “high.” If you have diabetes, tell your doctor about any skin sores.

You may have a higher chance for swelling and hives if you are also taking angiotensin-converting enzyme (ACE) inhibitors, so tell your doctor if you are taking these medications. You may have a higher chance of swelling of your hands or feet or gaining weight if you are also taking certain diabetes medicines. Do not drink alcohol while on LYRICA. You may have a higher chance for dizziness and sleepiness if you take LYRICA with alcohol, narcotic pain medicines, or medicines for anxiety.

Before you start LYRICA, tell your doctor if you are planning to father a child, if you are pregnant, or plan to become pregnant. Breastfeeding is not recommended while taking LYRICA. If you have had a drug or alcohol problem, you may be more likely to misuse LYRICA.

In studies, a specific type of blood vessel tumor was seen in mice. The meaning of these findings in humans is not known.

Do not stop taking LYRICA without talking to your doctor. If you stop suddenly, you may have headaches, nausea, diarrhea, trouble sleeping, increased sweating, or you may feel anxious. If you have epilepsy, you may have seizures more often.

INDICATIONS

LYRICA is indicated to treat fibromyalgia, diabetic nerve pain, spinal cord injury nerve pain, and pain after shingles in adult patients. LYRICA is also indicated to treat partial onset seizures in patients 4 years of age and older with epilepsy who take 1 or more other drugs for seizures.

Please see full Prescribing Information and Medication Guide.

Terms and conditions apply.

Message and data rates may apply. Patients may receive up to 4 messages to enroll and recurring messages per month. For information and terms of the LSAVINGS program, please visit www.LYRICA.com/xmt.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.

Patients should always ask their doctors for medical advice about adverse events.

You may report an adverse event related to Pfizer products by calling 1-800-438-1985 (US only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch.com or call
1-800-FDA-1088.

© 2019 Pfizer Inc. All rights reserved. PP-LYR-USA-3075

TERMS AND CONDITIONS

Offer Terms & Conditions

By using the Co-Pay Savings Card, you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions:

Patients are not eligible to use this card or participate in this program if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veteran Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”). Patient must have private insurance. Offer is not valid for cash paying patients. The value of this card is limited to $175 per month per prescription (“offering period”) or the amount of your co-pay, whichever is less (Maximum annual savings of $2100). This program is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs. You must deduct the value received under this program from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf. You are responsible for reporting use of this program to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the program, as may be required. You should not use the program if your insurer or health plan prohibits use of manufacturer co-pay cards. You must be 18 years of age or older to accept this offer. This offer is not valid where prohibited by law.

For Massachusetts residents:

This co-pay offer is not valid if an A/B generic is available for Massachusetts residents whose prescriptions are covered in whole or in part by third-party insurance.

For California residents:

This co-pay offer is not valid if a generic is available for California residents whose prescriptions are covered in whole or in part by third-party insurance.

Please check with your healthcare professional or insurer to confirm eligibility. This offer cannot be combined with any other savings, free trial or similar offer for the specified prescription. The co-pay card will be accepted only at participating pharmacies. The co-pay card is not health insurance. Offer good only in the U.S. and Puerto Rico. The co-pay card is limited to one per person during this offering period and is not transferable. A co-pay card may not be redeemed more than once per offering period per patient. No other purchase is necessary. Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer’s programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you. Pfizer reserves the right to rescind, revoke or amend this offer without notice. No membership fee. For more information, visit our website www.lyrica.com, call 1-866-954-1475, or contact us at 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560.

Offer expires 12/31/2020.

For reimbursement when using a nonparticipating pharmacy/mail order:

Pay for prescription, and mail copy of original pharmacy receipt (cash register receipt NOT valid) with product name, date, and amount circled to: Co-Pay Savings Card, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560. Be sure to include a copy of the front of your activated Co-Pay Savings Card, your name and mailing address.

Mobile Terms & Conditions:

By agreeing to the terms of the Pfizer LSAVINGS mobile program (the “Program”), you consent to receive autodialed text messages on behalf of Pfizer. Consent is not a condition of purchase or use of any Pfizer product or service. The Program is valid with most major U.S. carriers. There is no fee payable to Pfizer to receive text messages; however, your carrier’s message and data rates may apply. T-Mobile is NOT liable for delayed or undelivered messages.

Data obtained from you in connection with your registration for, and use of, the Program may include your phone number, related carrier information, and elements of pharmacy claim information, such as name, date of birth, and prescription information. You agree that such data may be used to administer the Program and to provide Program benefits such as savings offers, information about your prescription, including refill reminders and new prescription requests, as well as Program updates and alerts sent directly to your device.

For information on data collection and use, please read our Privacy Policy, which is incorporated by reference into these Terms.

Participants may receive up to 5 messages to enroll in the Program and recurring messages per month during the course of the Program. You may unsubscribe from the Program at any time by texting STOP to 597422. Doing so will only opt you out of the LSAVINGS mobile program; you will remain opted in to any other Pfizer Inc. text message program(s) to which you separately opted in. For help, text HELP to 597422. For questions about the Program, call 1-877-822-7855. You understand that you are responsible for notifying Pfizer immediately if you change your mobile telephone number. You agree to opt-out if the phone number that you previously provided is no longer associated with you. Pfizer reserves the right to rescind, revoke, or amend the Program without notice. You agree to review these Mobile Terms and Conditions periodically to ensure that you are aware of any changes. Your continued consent to receive text messages will indicate your acceptance of those changes.

E-mail Terms & Conditions:

By agreeing to the terms of LSAVINGS E-mail program (the “E-mail Program”), you consent to receive e-mail messages on behalf of Pfizer. Consent is not a condition of purchase or use of any Pfizer product or service.

Data obtained from you in connection with your registration for, and use of, the E-mail Program may include your e-mail address and elements of pharmacy claim information, such as name, date of birth, and prescription information. You agree that such data may be used to administer the E-mail Program and to provide E-mail Program benefits such as savings offers, information about your prescription, including refill reminders and new prescription requests, as well as E-mail Program updates and alerts sent directly to your e-mail address.

You may unsubscribe from the E-mail Program at any time by clicking on the unsubscribe link at the bottom of any E-Mail Program e-mail. Please do not reply to E-mail Program e-mails as it is an unattended e-mail box. A link to contact Pfizer is at the bottom of every E-mail Program e-mail. Pfizer reserves the right to rescind, revoke, or amend the E-mail Program without notice.